Intrathecal Prophylaxis With 12 vs 8 Administrations Reduces the Incidence of CNS Relapse Newly Diagnosed Ph+ ALL
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
American Journal of Hematology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Intrathecal prophylaxis with 12 versus 8 administrations reduces the incidence of central nervous system relapse in patients with newly diagnosed Philadelphia chromosome positive acute lymphoblastic leukemia
Am. J. Hematol 2022 May 28;[EPub Ahead of Print], S Paul, H Kantarjian, K Sasaki, K Marx, N Jain, JM Savoy, A DiPippo, N Jammal, GM Bravo, T Kadia, G Garcia-Manero, NJ Short, F Ravandi, E JabbourFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.